Home/Filings/4/0001415889-24-003999
4//SEC Filing

Cooper Simon Peter 4

Accession 0001415889-24-003999

CIK 0001664710other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 8:37 PM ET

Size

5.5 KB

Accession

0001415889-24-003999

Insider Transaction Report

Form 4
Period: 2024-02-13
Cooper Simon Peter
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-02-13+40,00040,000 total
    Exercise: $56.18Exp: 2034-02-12Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on February 13, 2025, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001877225

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:37 PM ET
Size
5.5 KB